Menu
Log in
  • Home
  • IDAC 38th Annual Southern California Symposium

IDAC 38th Annual Southern California Symposium

  • July 13, 2024
  • 7:30 AM
  • July 14, 2024
  • 1:00 PM
  • Huntington Beach Hyatt Regency

Registration


Register

IDAC 38th Annual Southern California Symposium July 13 - 14, 2024

Huntington Beach Hyatt Regency

Saturday, July 13

(Topics and Times Subject to Change)

0730 – 0830: Check-in, Breakfast Buffett - Industry exhibit visits

0830-0840Opening Remarks – Dr. Suman Radhakrishna, President, IDAC

0840 – 0940 - The Updated Duke Criteria: Work-up for Infective Endocarditis James McKinnell, MD, Infectious Disease Specialist, Milefchik-Rand Medical Group, Torrance Memorial Medical Center- In Memory of Arnold Bayer, MD

0940 – 1000 - Morning Break, Vendor Visits

1000 – 1100 - Complicated Infected Pacemaker Leads and Current Management Practices - RayShaerf, MD. Adjunct Clinical Associate Professor, Cedars-Sinai, Cardiac Surgery

1100-1200 - Surgical Indications for Infective Endocarditis and How to Prevent Post-operative Infections – Loren Miller, MD, MPH, Investigator -The Lundquist Institute, Associate Chief - Division of Infectious Diseases, Department of Medicine - Harbor-UCLA Medical Center, Professor of Medicine - David Geffen School of Medicine at UCLA

1200 – 1315 - Lunch, Vendor Visits,

12:30 - Breakout Sessions - Members Meeting

1315 – 1415Antibiotic Selection for Infective Endocarditis - Review of the Basics – Jim Lewis, Pharm D, FIDSA, Clinical Supervisor for Infectious Disease, Oregon Health and Science University

1415 – 1430 - Afternoon Break, Industry exhibit visits

1430 – 1530 Antibiotic Selection for Infective Endocarditis - How to Manage the Impossible, Deep Salvage for MRSA, MSSA, VRE, Gram Negatives, Fungi - George Sakoulas, MD, Adjunct Professor of Pediatrics at the University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics

1530 – 1630 - Outcomes - Oral Antibiotic Treatment for Endocarditis (Poet and New Lancet Study on Oral Antimicrobials for MRSA) – Jim Lewis, Pharm D, FIDSA, Clinical Supervisor for Infectious Disease, Oregon Health and Science University

Sunday, July 14

0730 – 0830 -   Breakfast Buffett, Industry exhibit visits

0830-0840Welcome - Dr. Suman Radhakrishna, IDAC President

0840 – 0940 - Dalbavancin for Complicated Staph Bacteremia & Right Sided Endocarditis: Results from the DOTS Trial  Nicholas Turner, MD, MHSc, Assistant Professor of Medicine, Infectious Diseases, Duke University

1000 – 1100 – Expanding Hospital Bloodstream Infection Surveillance: Infection Prevention Strategies in PIV Surveillance and Hospital-Onset Bacteremia and Fungemia-  Jessica Alicdan, MPH, CIC. Infection Preventionist, UC San Diego Health, Department of Infection Prevention and Clinical Epidemiology (IPCE)

1100-1200 - The Power of Plasma Microbial Cell-Free DNA: Real World Application of A Liquid Biopsy for Infective Endocarditis -Uriel S. Sandkovsky, M.D., M.S.  Infectious Diseases Attending Physician, Baylor University Medical Center at Dallas, Transplant and Clinical Infectious Diseases Attending, North Texas Infectious Disease Consultants

1200Symposium Ends



Powered by Wild Apricot Membership Software